ESR1 and breast carcinoma: To systematically determine the impact of TRIM25 on p300-depedent gene expression in yet another context, we performed RNA-seq in the estrogen receptor α-dependent breast cancer cell line MCF7, in which TRIM25 was knocked-out by CRISPR/Cas9 (Fig S7A).